Shoulder Innovations, Inc.

SI Healthcare Medical Devices

Shoulder Innovations, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $47.3 million, up 49.6% from fiscal 2024. In the quarter to June 2026, revenue grew 56.0%, EPS grew 99.7%, free cash flow fell 52.4% and total debt was flat, each against the same quarter a year earlier. Insiders bought in the last twelve months.

18.09 0.28 −1.52%
Market cap
$382.4M
P/E
0.0×
Fwd P/E
−8.4×
Dividend yield
—
F-score
n/a
Altman Z
2.53
Beneish M
−2.42
Dividend safety
n/a
Dec '24 Dec '25
P/E ratio
0.00 0.00
Altman Z-Score
— 2.53
P/S ratio
0.05 2.62
Altman Z″-Score (non-manufacturers)
(1.53) 7.68
P/FCF ratio
0.00 0.00
P/Operating CF
(0.36) (14.12)
Beneish M-Score
— (2.42)
P/B ratio
0.00 0.88
EV/Sales
(0.63) 0.31
EV/EBITDA
1.45 0.00
EV/FCF
0.98 (0.41)
Current Ratio
4.59 11.07
Net Debt/EBITDA
0.03 4.79
Debt/Equity
0.74 0.11
ROE
0.00% (93.80%)
ROA
0.00% (37.90%)
ROIC
(47.22%) (52.42%)
Return on Tangible Assets
(44.67%) (25.95%)
Average Days of Receivables
59.12 63.78
Earnings Yield
(2,386.39%) (1,529.23%)
Free Cash Flow Yield
(1,356.23%) (29.04%)
Free Cash Flow per Share
(281.52) (4.15)
Book value per Share
306.67 16.23
Free Cash Flow
(18.16) (36.02)
EV/EBIT
1.28 0.00
Other line items

Show all line items

Columns are period end dates